Treatment of Bacterial Vaginosis
For symptomatic bacterial vaginosis, prescribe oral metronidazole 500 mg twice daily for 7 days, which achieves a 95% cure rate and remains the gold standard first-line treatment. 1, 2
First-Line Treatment Options
The CDC recommends three equally acceptable first-line regimens for non-pregnant women: 3, 1
Oral metronidazole 500 mg twice daily for 7 days - This achieves the highest cure rate at 95% and should be your default choice 3, 1, 2
Metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days - Equally effective as oral therapy (75-84% cure rate) but with significantly fewer systemic side effects since serum concentrations reach less than 2% of oral dosing 3, 1, 2
Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days - Achieves 82% cure rate and is particularly useful for patients with metronidazole intolerance 3, 1, 2
Critical Patient Counseling Points
Alcohol avoidance is mandatory - Patients on metronidazole must avoid alcohol during treatment and for 24 hours afterward due to disulfiram-like reactions 3, 1, 2
Condom warning - Clindamycin cream is oil-based and will weaken latex condoms and diaphragms for several days after use 3, 4, 2
Alternative Treatment Options (Lower Efficacy)
Oral metronidazole 2g single dose - Only 84% cure rate compared to 95% for the 7-day regimen, but may be appropriate when compliance is a major concern 3, 1, 2
Oral clindamycin 300 mg twice daily for 7 days - Reserve for metronidazole-intolerant patients 3, 2
Tinidazole 2g once daily for 2 days or 1g once daily for 5 days - FDA-approved with therapeutic cure rates of 22-32% (though measured by stricter criteria than older studies), useful as an alternative nitroimidazole 5
Special Populations
Pregnancy
All symptomatic pregnant women must be tested and treated for BV due to associations with preterm delivery and premature rupture of membranes. 3, 1, 2
First trimester: Use clindamycin vaginal cream 2% nightly for 7 days - metronidazole is contraindicated in first trimester 3, 1
Second and third trimesters: Metronidazole 250 mg orally three times daily for 7 days is the recommended regimen 1, 2, 6
High-risk pregnant women (prior preterm delivery): Treatment may reduce prematurity risk, making screening and treatment particularly important even if asymptomatic 3, 1, 2
HIV-Infected Patients
Breastfeeding Women
Standard CDC guidelines apply - metronidazole is compatible with breastfeeding as only small amounts are excreted in breast milk 1
Intravaginal preparations minimize systemic exposure if there are concerns 1
Metronidazole Allergy or Intolerance
Use clindamycin cream 2% intravaginally for 7 days or oral clindamycin 300 mg twice daily for 7 days 3, 1, 4, 2
Never give metronidazole gel to patients with oral metronidazole allergy - cross-reactivity occurs 3, 1
Recurrent Bacterial Vaginosis
Recurrence affects up to 50% of women within one year, often due to biofilm formation that protects bacteria from antimicrobials. 7
For recurrent BV after initial treatment failure: 4, 7
Extended metronidazole: 500 mg orally twice daily for 10-14 days 7
If extended course fails: Metronidazole gel 0.75% for 10 days, then twice weekly for 3-6 months as suppressive maintenance 4, 7
Consider clindamycin-based regimens for suspected metronidazole resistance 4, 7
Follow-Up and Partner Management
No follow-up visit needed if symptoms resolve - patients should return only if symptoms recur 3, 1, 2
Do not treat male sex partners routinely - partner treatment has not been shown to influence cure rates or reduce recurrence 3, 1, 2
Pre-Procedural Considerations
Screen and treat BV before surgical abortion or hysterectomy - treatment with metronidazole substantially reduces post-abortion PID and other postoperative infectious complications 3, 1
Common Pitfalls to Avoid
Don't use the single-dose 2g metronidazole regimen as first-line - its 84% cure rate is significantly lower than the 95% achieved with the 7-day regimen 3, 2
Don't forget to warn about alcohol with metronidazole - the disulfiram reaction can be severe 3, 1
Don't assume vaginal candidiasis won't occur - approximately 12-30% of patients develop post-treatment yeast infections regardless of which BV treatment is used 8
Don't treat asymptomatic BV in non-pregnant, low-risk women unless they're undergoing invasive procedures 3, 1